home / openregs / documents

documents: FDA-2011-D-0605-0059

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2011-D-0605-0059 FDA FDA-2011-D-0605 Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies; Draft Guidance for Industry; Availability Notice Notice of Availability 2025-11-20T05:00:00Z 2025 11 2025-11-20T05:00:00Z   2025-11-20T19:15:15Z 2025-20380 0 0 09000064b908a856

Links from other tables

  • 1 row from regs_document_id in fr_regs_crossref
Powered by Datasette · Queries took 1856.444ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API